Clinical Trial

Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals With Spinal Cord Injuries

Study acronym: MIH and AD
Recruiting
View on ClinicalTrials.gov →
Summary
The prevalence of autonomic dysfunction and sleep disordered breathing (SDB) is increased in individuals with spinal cord injury (SCI). The loss of autonomic control results in autonomic dysreflexia (AD) and orthostatic hypotension (OH) which explains the increase in cardiovascular related mortality in these Veterans. There is no effective prophylaxis for autonomic dysfunction. The lack of prophylactic treatment for autonomic dysfunction, and no best clinical practices for SDB in SCI, are significant health concerns for Veterans with SCI. Therefore, the investigators will investigate the effectiveness of mild intermittent hypoxia (MIH) as a prophylactic for autonomic dysfunction in patients with SCI. The investigators propose that MIH targets several mechanisms associated with autonomic control and the co-morbidities associated with SDB. Specifically, exposure to MIH will promote restoration of homeostatic BP control, which would be beneficial to participation in daily activities and independence in those with SCI.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-10-29 -> 2027-10-29 2026-08-15
minor Completion pushed: 2026-10-29 -> 2027-10-29 2026-08-15
Trial Details
NCT Number NCT05351827
Lead Sponsor VA Office of Research and Development
Collaborators: John D. Dingell VA Medical Center
Conditions Spinal Cord Injuries, Autonomic Dysreflexia
Enrollment 24 participants
Start Date 2022-10-01
Primary Completion 2027-10-29 (estimated)
Study Completion 2027-10-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-14